Royal Bank of Canada’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7K | Sell |
1,612
-98
| -6% | -$426 | ﹤0.01% | 6199 |
|
|
2025
Q1 | $7K | Sell |
1,710
-53,967
| -97% | -$221K | ﹤0.01% | 5893 |
|
|
2024
Q4 | $436K | Buy |
55,677
+45,327
| +438% | +$355K | ﹤0.01% | 3743 |
|
|
2024
Q3 | $136K | Buy |
10,350
+6,891
| +199% | +$90.5K | ﹤0.01% | 4689 |
|
|
2024
Q2 | $42K | Buy |
3,459
+2,622
| +313% | +$31.8K | ﹤0.01% | 5352 |
|
|
2024
Q1 | $13K | Sell |
837
-9,540
| -92% | -$148K | ﹤0.01% | 5665 |
|
|
2023
Q4 | $71K | Buy |
10,377
+4,910
| +90% | +$33.6K | ﹤0.01% | 5290 |
|
|
2023
Q3 | $30K | Buy |
5,467
+2,332
| +74% | +$12.8K | ﹤0.01% | 5538 |
|
|
2023
Q2 | $21K | Buy |
3,135
+1,056
| +51% | +$7.07K | ﹤0.01% | 5737 |
|
|
2023
Q1 | $10K | Sell |
2,079
-6,581
| -76% | -$31.7K | ﹤0.01% | 5952 |
|
|
2022
Q4 | $42K | Buy |
8,660
+2,844
| +49% | +$13.8K | ﹤0.01% | 5521 |
|
|
2022
Q3 | $84K | Buy |
5,816
+297
| +5% | +$4.29K | ﹤0.01% | 4948 |
|
|
2022
Q2 | $83K | Sell |
5,519
-3,952
| -42% | -$59.4K | ﹤0.01% | 5006 |
|
|
2022
Q1 | $113K | Sell |
9,471
-3,252
| -26% | -$38.8K | ﹤0.01% | 5090 |
|
|
2021
Q4 | $206K | Sell |
12,723
-2,837
| -18% | -$45.9K | ﹤0.01% | 4791 |
|
|
2021
Q3 | $444K | Buy |
15,560
+690
| +5% | +$19.7K | ﹤0.01% | 3984 |
|
|
2021
Q2 | $503K | Buy |
14,870
+5,564
| +60% | +$188K | ﹤0.01% | 3831 |
|
|
2021
Q1 | $282K | Buy |
9,306
+473
| +5% | +$14.3K | ﹤0.01% | 4200 |
|
|
2020
Q4 | $437K | Buy |
8,833
+1,394
| +19% | +$69K | ﹤0.01% | 3754 |
|
|
2020
Q3 | $286K | Buy |
7,439
+1,818
| +32% | +$69.9K | ﹤0.01% | 3830 |
|
|
2020
Q2 | $242K | Buy |
5,621
+5,505
| +4,746% | +$237K | ﹤0.01% | 3870 |
|
|
2020
Q1 | $3K | Sell |
116
-503
| -81% | -$13K | ﹤0.01% | 5716 |
|
|
2019
Q4 | $19K | Buy |
+619
| New | +$19K | ﹤0.01% | 5279 |
|